Actions of bisphosphonates in animal models of breast cancer

Susan S. Padelecki, Theresa A. Guise

Research output: Contribution to journalReview article

33 Citations (Scopus)

Abstract

The skeleton is the most common site of breast cancer metastases. These bone metastases are usually osteolytic and cause significant morbidity. Bisphosphonates, potent inhibitors of bone resorption, reduce skeletal morbidity in breast cancer patients with bone metastases. Animal studies with bisphosphonates are crucial to understanding the mechanisms by which these compounds affect bone and tumor cells in vivo. Such animal models of breast cancer that are used to test the efficacy of bisphosphonates are discussed. These studies may offer insight into the treatment of other tumor types that frequently metastasize to bone.

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalBreast Cancer Research
Volume4
Issue number1
DOIs
StatePublished - Feb 5 2002

Fingerprint

Diphosphonates
Animal Models
Breast Neoplasms
Bone and Bones
Neoplasm Metastasis
Bone Density Conservation Agents
Morbidity
Skeleton
Neoplasms
Therapeutics

Keywords

  • Animal models
  • Bisphosphonate
  • Breast cancer
  • Metastases
  • Skeletal metastases

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Actions of bisphosphonates in animal models of breast cancer. / Padelecki, Susan S.; Guise, Theresa A.

In: Breast Cancer Research, Vol. 4, No. 1, 05.02.2002, p. 35-41.

Research output: Contribution to journalReview article

@article{282935e7b1784b57a169504685c7ad3f,
title = "Actions of bisphosphonates in animal models of breast cancer",
abstract = "The skeleton is the most common site of breast cancer metastases. These bone metastases are usually osteolytic and cause significant morbidity. Bisphosphonates, potent inhibitors of bone resorption, reduce skeletal morbidity in breast cancer patients with bone metastases. Animal studies with bisphosphonates are crucial to understanding the mechanisms by which these compounds affect bone and tumor cells in vivo. Such animal models of breast cancer that are used to test the efficacy of bisphosphonates are discussed. These studies may offer insight into the treatment of other tumor types that frequently metastasize to bone.",
keywords = "Animal models, Bisphosphonate, Breast cancer, Metastases, Skeletal metastases",
author = "Padelecki, {Susan S.} and Guise, {Theresa A.}",
year = "2002",
month = "2",
day = "5",
doi = "10.1186/bcr415",
language = "English (US)",
volume = "4",
pages = "35--41",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Actions of bisphosphonates in animal models of breast cancer

AU - Padelecki, Susan S.

AU - Guise, Theresa A.

PY - 2002/2/5

Y1 - 2002/2/5

N2 - The skeleton is the most common site of breast cancer metastases. These bone metastases are usually osteolytic and cause significant morbidity. Bisphosphonates, potent inhibitors of bone resorption, reduce skeletal morbidity in breast cancer patients with bone metastases. Animal studies with bisphosphonates are crucial to understanding the mechanisms by which these compounds affect bone and tumor cells in vivo. Such animal models of breast cancer that are used to test the efficacy of bisphosphonates are discussed. These studies may offer insight into the treatment of other tumor types that frequently metastasize to bone.

AB - The skeleton is the most common site of breast cancer metastases. These bone metastases are usually osteolytic and cause significant morbidity. Bisphosphonates, potent inhibitors of bone resorption, reduce skeletal morbidity in breast cancer patients with bone metastases. Animal studies with bisphosphonates are crucial to understanding the mechanisms by which these compounds affect bone and tumor cells in vivo. Such animal models of breast cancer that are used to test the efficacy of bisphosphonates are discussed. These studies may offer insight into the treatment of other tumor types that frequently metastasize to bone.

KW - Animal models

KW - Bisphosphonate

KW - Breast cancer

KW - Metastases

KW - Skeletal metastases

UR - http://www.scopus.com/inward/record.url?scp=0036148327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036148327&partnerID=8YFLogxK

U2 - 10.1186/bcr415

DO - 10.1186/bcr415

M3 - Review article

C2 - 11879558

AN - SCOPUS:0036148327

VL - 4

SP - 35

EP - 41

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 1

ER -